CAS 313368-91-1

Lumateperone

Description:

Lumateperone, identified by its CAS number 313368-91-1, is an atypical antipsychotic medication primarily used for the treatment of schizophrenia in adults. It exhibits a unique mechanism of action, functioning as a modulator of various neurotransmitter systems, including dopamine and serotonin receptors. Lumateperone is characterized by its ability to balance dopaminergic activity, which may help mitigate both positive and negative symptoms of schizophrenia with a potentially lower risk of extrapyramidal side effects compared to traditional antipsychotics. The compound is typically administered orally and has a favorable pharmacokinetic profile, allowing for once-daily dosing. Its chemical structure includes a sulfonamide moiety, contributing to its pharmacological properties. Lumateperone has been shown to improve overall functioning and quality of life in patients, making it a valuable option in the management of schizophrenia. As with any medication, it is essential to consider potential side effects and contraindications, and it should be prescribed and monitored by a qualified healthcare professional.

Formula: C₂₄H₂₈FN₃O

Lumateperone-d4 Ditosylate

CAS: 1187020-80-9, 313368-91-1

Formula: C₂₄H₂₄D₄FN₃O·2C₇H₈O₃S

Molecular weight: 397.53 2*172.20

Ref: 4Z-L-168008

Lumateperone

CAS: 313368-91-1

Lumateperone

Purity: ≥98%

Molecular weight: 393.5g/mol

Ref: 54-BUP06902

Lumateperone

Controlled Product

CAS: 313368-91-1

Formula: C₂₄H₂₈FN₃O

Color and Shape: Neat

Molecular weight: 393.497

Ref: TR-L495900

Lumateperone

CAS: 313368-91-1

Lumateperone (ITI 722) is a 5HT2A receptor antagonist and a dopamine receptor phosphoprotein modulator (DPPM).

Formula: C₂₄H₂₈FN₃O

Purity: 99.68% - 99.91%

Color and Shape: Solid

Molecular weight: 393.5

Ref: TM-T21069